DMS contracts with hospitals and health care systems to provide mobile imaging services on site – we do not provide home-based imaging services.
Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients...
This post was written by John W. Mitchell and first appeared on DOTmed HealthCare Business Daily News. It has been reposted here with permission of the publisher. Two sources report that they are responding to rapidly changing demands of their hospital clients during...
Prostate cancer is a leading cause of death among US men. Advances in imaging are helping to detect it earlier – here is where prostate imaging is heading.
Alzheimer’s disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimer’s or another dementia, making it a bigger killer than breast and prostate cancer combined. In fact, deaths from Alzheimer’s disease...
The entire medical system of the United States has been focused on a single threat over the past eight weeks. While the dangers from COVID-19 remain present, many states are beginning to open back up, and as capacity increases, medical facilities are easing back into...
While PET MPI has seen increased interest among cardiologists, financial constraints and availability concerns have kept the modality from gaining traction in the US market. The current set of radiopharmaceuticals has built-in drawbacks, but recent innovations could...
How reliant is your medical facility on your imaging suite? For most hospitals and clinics, certain aspects of diagnosis and treatment decisions can’t happen without the availability of imaging. You can’t guide a catheter for angioplasty without the assistance of...
While the majority of the current COVID-19 related news pertains to the care and treatment of patients with confirmed coronavirus cases, there is emerging data about the complications that can arise after a patient recovers from the virus.New JAMA StudyA recent...
Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients...
This post was written by John W. Mitchell and first appeared on DOTmed HealthCare Business Daily News. It has been reposted here with permission of the publisher. Two sources report that they are responding to rapidly changing demands of their hospital clients during...
Prostate cancer is a leading cause of death among US men. Advances in imaging are helping to detect it earlier – here is where prostate imaging is heading.
Alzheimer’s disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimer’s or another dementia, making it a bigger killer than breast and prostate cancer combined. In fact, deaths from Alzheimer’s disease...
The entire medical system of the United States has been focused on a single threat over the past eight weeks. While the dangers from COVID-19 remain present, many states are beginning to open back up, and as capacity increases, medical facilities are easing back into...
While PET MPI has seen increased interest among cardiologists, financial constraints and availability concerns have kept the modality from gaining traction in the US market. The current set of radiopharmaceuticals has built-in drawbacks, but recent innovations could...
How reliant is your medical facility on your imaging suite? For most hospitals and clinics, certain aspects of diagnosis and treatment decisions can’t happen without the availability of imaging. You can’t guide a catheter for angioplasty without the assistance of...
While the majority of the current COVID-19 related news pertains to the care and treatment of patients with confirmed coronavirus cases, there is emerging data about the complications that can arise after a patient recovers from the virus.New JAMA StudyA recent...